Research Alert

Newswise — Article title: Amelioration of metabolic syndrome by metformin associates with reduced indices of low-grade inflammation independently of the gut microbiota

Authors: Aneseh Adeshirlarijaney, Jun Zou, Hao Tran, Benoit Chassaing, Andrew T. Gewirtz

From the authors: “These results support a role for metformin’s anti-inflammatory activity, irrespective of gut microbiota, in driving some of this drug’s beneficial impacts on metabolic syndrome.”

This study is highlighted as one of December's "best of the best" as part of the American Physiological Society's APSselect program.

 

SEE ORIGINAL STUDY